RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL
· Real-Time Price · USD
1.37
-0.02 (-1.44%)
At close: Aug 15, 2025, 3:59 PM
1.39
1.36%
After-hours: Aug 15, 2025, 06:45 PM EDT
RedHill Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.74M | 2.74M | 1.29M | 1.29M | 567.5K | 567.5K | 1.8M | 3.6M | 12.8M | 17.55M | 18.35M | 18.24M | 22.07M | 21.61M | 21.5M | 20.57M |
Cost of Revenue | 894K | 894K | 702K | 702K | 520.5K | 520.5K | 806K | 1.61M | 8.6M | 9.45M | 8.99M | 8.03M | 19.33M | 9.23M | 10.59M | 10.25M |
Gross Profit | 1.84M | 1.84M | 584K | 584K | 47K | 47K | 990K | 1.99M | 4.2M | 8.1M | 9.35M | 10.2M | 2.74M | 12.38M | 10.91M | 10.32M |
Operating Income | -3.08M | -3.08M | -4.22M | -4.22M | -6.02M | -6.02M | -4.41M | 50.66M | -9.95M | -7.11M | -9.16M | -13.24M | -20.7M | -17.4M | -24.89M | -18.15M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 7.09M | 21.58M | 11.27M | 3.19M | 1.66M | 10K | 12.05K | 17K | 15K | 42K |
Pretax Income | -2.59M | -2.59M | -1.54M | -1.54M | -13.54M | -13.54M | 761K | 50.24M | -3.73M | -35.7M | -11.71M | -17.14M | -24.37M | -21.39M | -29.12M | -22.86M |
Net Income | -2.59M | -2.59M | -1.54M | -1.54M | -13.54M | -13.54M | 761K | 50.24M | -3.73M | -35.7M | -11.71M | -20.53M | -24.37M | -21.39M | -29.12M | -22.86M |
Selling & General & Admin | 3.28M | 3.28M | 4.48M | 4.48M | 6M | 6M | 8.06M | 10.91M | 13.02M | 13.6M | 17.04M | 20.38M | 17.57M | 23.96M | 25.47M | 20.99M |
Research & Development | 464.5K | 464.5K | 329.5K | 329.5K | 598.5K | 598.5K | 1.25M | 1.08M | 1.13M | 1.61M | 1.47M | 3.06M | 5.87M | 5.82M | 10.33M | 7.48M |
Other Expenses | 1.18M | 1.18M | n/a | n/a | -535.5K | -535.5K | -3.91M | -39.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.92M | 4.92M | 4.81M | 4.81M | 6.07M | 6.07M | 5.4M | -27.09M | 14.15M | 15.21M | 18.51M | 23.44M | 23.44M | 29.78M | 35.8M | 28.47M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1.93M | 421K | n/a | 31.78M | 4.21M | 3.91M | 3.7M | 4.01M | 4.25M | 4.75M |
Selling & Marketing Expenses | 1.23M | 1.23M | 1.74M | 1.74M | 2.56M | 2.56M | 4.52M | 5.11M | -19.87M | 7.09M | 9.27M | 12.56M | -33.27M | 15.53M | 15.23M | 13.89M |
Cost & Expenses | 5.82M | 5.82M | 5.51M | 5.51M | 6.59M | 6.59M | 6.2M | -25.48M | 22.75M | 24.66M | 27.5M | 31.47M | 42.77M | 39.01M | 46.39M | 38.73M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 421K | n/a | n/a | n/a | 10K | -81K | 17K | 15K | 42K |
Shares Outstanding (Basic) | 2.58M | 2.58M | 2.35M | 2.35M | 780.9K | 548.13K | 315.36K | 194.8K | 186.39K | 127.67K | 113.66K | 105.37K | 99.84K | 93.58K | 93.36K | 85.92K |
Shares Outstanding (Diluted) | 2.58M | 2.58M | 2.35M | 2.35M | 780.9K | 548.13K | 315.36K | 194.8K | 186.39K | 127.67K | 113.66K | 105.37K | 99.84K | 93.58K | 93.36K | 85.92K |
EPS (Basic) | -1 | -1 | -0.66 | -0.66 | -17 | -24 | 3.00 | 256.00 | -20 | -282 | -103 | -195 | -244 | -228 | -312 | -266 |
EPS (Diluted) | -1 | -1 | -0.66 | -0.66 | -17 | -24 | 3.00 | 256.00 | -20 | -282 | -103 | -195 | -244 | -228 | -312 | -266 |
EBITDA | -1.88M | -1.82M | -4.01M | -4.01M | -5.84M | -5.64M | 2.69M | 50.64M | 757.97K | -1.81M | -5.52M | -14.49M | -9.59M | -15.06M | -22.59M | -15.83M |
EBIT | -1.9M | -1.9M | -4.22M | -4.22M | -6.02M | -6.02M | 2.69M | 50.19M | -2.3M | -3.92M | -7.5M | -16.62M | -20.78M | -17.38M | -24.87M | -18.11M |
Depreciation & Amortization | 24.5K | 86K | 209K | 209K | 178.5K | 383.17K | 1.11M | 455.69K | 2M | 2.08M | 1.89M | 2.14M | 11.24M | 2.35M | 2.3M | 2.29M |